Mishima Gerhart
General Counsel bij PLIANT THERAPEUTICS, INC.
Profiel
Mishima Gerhart is currently the Chief Regulatory Officer at Pliant Therapeutics, Inc. Prior to this, Mishima held positions as the Head-Regulatory Affairs at Genzyme Corp.
from 2014 to 2016, and as the Head-Global Regulatory Affairs at Sanofi from 2016 to 2020.
Mishima also served as the Chief Regulatory Officer & Head-Quality at Taysha Gene Therapies, Inc. Mishima's education includes an undergraduate degree from Kutztown University of Pennsylvania and a graduate degree from Temple University (Pennsylvania).
Actieve functies van Mishima Gerhart
| Bedrijven | Functie | Begin |
|---|---|---|
| PLIANT THERAPEUTICS, INC. | General Counsel | 16-10-2023 |
Eerdere bekende functies van Mishima Gerhart
| Bedrijven | Functie | Einde |
|---|---|---|
| SANOFI | General Counsel | 01-06-2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | 01-01-2016 |
| TAYSHA GENE THERAPIES, INC. | General Counsel | - |
Opleiding van Mishima Gerhart
| Kutztown University of Pennsylvania | Undergraduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| SANOFI | Commercial Services |
| PLIANT THERAPEUTICS, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
